Matrix metalloproteinases in necrotising enterocolitis

Pediatric Research

Volumn 54, Issue 2, 2003, Pages 160-164

  Pender, Sylvia Lin Foon ^a,e   Braegger, Christian ^b   Günther, Ute ^a   Monteleone, Giovanni ^c   Meuli, Martin ^b   Schuppan, Detlef ^d   Macdonald, Thomas Thornton ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ALPHA SMOOTH MUSCLE ACTIN; COLLAGENASE; GAMMA INTERFERON; GELATINASE; GELATINASE A; MATRIX METALLOPROTEINASE; MESSENGER RNA; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; ENZYMOLOGY; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IN SITU HYBRIDIZATION; INFANT; INTESTINE MUCOSA; METABOLISM; NECROTIZING ENTEROCOLITIS; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

ENTEROCOLITIS, NECROTIZING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INFANT, NEWBORN; INTERFERON TYPE II; INTESTINAL MUCOSA; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MYOCYTES, SMOOTH MUSCLE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0043173634     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000072326.23442.C3     Document Type: Article

References (30)

1. Kliegman RM, Fanaroff AA 1984 Necrotizing enterocolitis. N Engl J Med 310:1093-1103
2. Wilson R, Kanto WP, Jr., McCarthy BJ, Burton T, Lewin P, Terry J, Feldman RA 1981 Epidemiologic characteristics of necrotizing enterocolitis: a population-based study. Am J Epidemiol 114:880-887
3. Stoll BJ, Kanto WP, Jr., Glass RI, Nahmias AJ, Brann AW, Jr 1980 Epidemiology of necrotizing enterocolitis: a case control study. J Pediatr 96:447-451
4. Kliegman RM 1979 Neonatal necrotizing enterocolitis: implications for an infectious disease. Pediatr Clin North Am 26:327-344
5. Heuschkel RB, MacDonald TT, Monteleone G, Bajaj-Elliott M, Smith JA, Pender SL 2000 Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease. Gut 47:57-62
6. Pender SL, Tickle SP, Docherty AJ, Howie D, Wathen NC, MacDonald TT 1997 A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol 158:1582-1590
7. Murphy G, Docherty AJ 1992 The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 7:120-125
8. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA 1993 Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4:197-250
9. Nagase H, Woessner JF 1999 Matrix metalloproteinases. J Biol Chem 274:21491-21494
10. de Coignac AB, Elson G, Delneste Y, Magistrelli G, Jeannin P, Aubry JP, Berthier O, Schmitt D, Bonnefoy JY, Gauchat JF 2000 Cloning of MMP-26 A novel matrilysin-like proteinase. Eur J Biochem 267:3323-3329
11. Brown PD 1998 Matrix metalloproteinases in gastrointestinal cancer. Gut 43:161-163
12. Kahari VM, Saarialho-Kere U 1999 Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med 31:34-45
13. Caplan MS, Hsueh W 1990 Necrotizing enterocolitis: role of platelet activating factor, endotoxin, and tumor necrosis factor. J Pediatr 117:S47-S51
14. Harris MC, Costarino AT, Jr., Sullivan JS, Dulkerian S, McCawley L, Corcoran L, Butler S, Kilpatrick L 1994 Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis. J Pediatr 124:105-111
15. Morecroft JA, Spitz L, Hamilton PA, Holmes SJ 1994 Plasma cytokine levels in necrotizing enterocolitis. Acta Paediatr Suppl 396:18-20
16. Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, Morzycka-Wroblewska E, Kagnoff MF 1995 A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 95:55-65
17. Monteleone G, MacDonald TT, Wathen NC, Pallone F, Pender SL 1999 Enhancing Lamina propria Th1 cell responses with interleukin 12 produces severe tissue injury. Gastroenterology 117:1069-1077
18. Tarnuzzer RW, Macauley SP, Farmerie WG, Caballero S, Ghassemifar MR, Anderson JT, Robinson CP, Grant MB, Humphreys-Beher MG, Franzen L, Peck AB, Schultz GS 1996 Competitive RNA templates for detection and quantitation of growth factors, cytokines, extracellular matrix components and matrix metalloproteinases by RT-PCR. Biotechniques 20:670-674
19. Herbst H, Wege T, Milani S, Pellegrini G, Orzechowski HD, Bechstein WO, Neuhaus P, Gressner AM, Schuppan D 1997 Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol 150:1647-1659
20. Milani S, Herbst H, Schuppan D, Surrenti C, Riecken EO, Stein H 1990 Cellular localization of type I III and IV procollagen gene transcripts in normal and fibrotic human liver. Am J Pathol 137:59-70
21. Pender SL, Fell JM, Chamow SM, Ashkenazi A, MacDonald TT 1998 A p55 TNF receptor immunoadhesin prevents T cell-mediated intestinal in injury by inhibiting matrix metalloproteinase production. J Immunol 160:4098-4103
22. Pender SL, Breese EJ, Gunther U, Howie D, Wathen NC, Schuppan D, MacDonald TT 1998 Suppression of T cell-mediated injury in human gut by interleukin-10: role of matrix metalloproteinases. Gastroenterology 115:573-583
23. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G 1999 Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10:387-398
24. Ford HR, Sorrells DL, Knisely AS 1996 Inflammatory cytokines, nitric oxide, and necrotizing enterocolitis. Semin Pediatr Surg 5:155-159
25. Ford H, Watkins S, Reblock K, Rowe M 1997 The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 32:275-282
26. Jurges ES, Henderson DC 1996 Inflammatory and immunological markers in preterm infants: correlation with disease. Clin Exp Immunol 105:551-555
27. Clark DA, Thompson JE, Weiner LB, McMillan JA, Schneider AJ, Rokahr JE 1985 Necrotizing enterocolitis: intraluminal biochemistry in human neonates and a rabbit model. Pediatr Res 19:919-921
28. Clark DA, Miller MJ 1990 Intraluminal pathogenesis of necrotizing enterocolitis. J Pediatr 117:S64-S67
29. Kien CL 1996 Digestion, absorption, and fermentation of carbohydrates in the newborn. Clin Perinatol 23:211-228
30. Pender SL, Quinn JJ, Sanderson IR, MacDonald TT 2000 Butyrate upregulates stromelysin-1 production by intestinal mesenchymal cells. Am J Physiol Gastrointest Liver Physiol 279:G918-G924